DNTH
#1232
Dianthus Therapeutics, Inc. - Common Stock
105.8 4 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.11%
Monthly Change
+1.61%
6 month change
+96.58%
Year Change
+352.50%
Previous Close
111.5 4
Open
105.8 4
Low
105.8 4
High
105.8 4
Volume
71
Financials
- Market Capitalization 5.92 B
- Employee 92
- Founded 2019
- CEO N/A
- Website www.dianthustx.com
- Headquarter Delaware, United States
- FIGI BBG00FB2NPZ0
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-9.81
Price to sales ratio
781.65
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1221 |  COGT Cogent Biosciences, Inc. - Common Stock | 34.67 USD | -6.52% | -5.66% | -12.98% | +121.25% | 6.02 B USD | ||
| 1225 |  BLTE Belite Bio Inc - American Depositary Shares | 151.72 USD | -3.37% | -5.80% | -1.71% | +144.00% | 5.97 B USD | ||
| 1240 |  PTCT PTC Therapeutics, Inc. - Common Stock | 70.09 USD | -2.40% | +0.60% | -4.50% | +41.68% | 5.85 B USD | ||
| 1248 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 59.99 USD | -3.13% | -1.28% | -4.67% | +47.07% | 5.81 B USD |
Frequently asked questions about Dianthus Therapeutics, Inc. Common Stock
What is the Dianthus Therapeutics, Inc. Common Stock stock price today?
The current price of Dianthus Therapeutics, Inc. Common Stock (DNTH) is 105.84. Over the past 24 hours, the stock has changed by -5.11%. Follow the DNTH chart for real-time price dynamics.
What is the stock ticker of Dianthus Therapeutics, Inc. Common Stock?
Dianthus Therapeutics, Inc. Common Stock trades under the ticker DNTH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Dianthus Therapeutics, Inc. Common Stock stock going up?
DNTH has changed by -3.85% over the last week, +1.61% over the last month, and +352.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Dianthus Therapeutics, Inc. Common Stock?
Dianthus Therapeutics, Inc. Common Stock currently has a market capitalization of 5.92 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Dianthus Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Dianthus Therapeutics, Inc. Common Stock reported earnings of -0.9 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Dianthus Therapeutics, Inc. Common Stock revenue for the last quarter?
Dianthus Therapeutics, Inc. Common Stock reported quarterly revenue of 11.53 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Dianthus Therapeutics, Inc. Common Stock net income for the last quarter?
Dianthus Therapeutics, Inc. Common Stock reported net income of -50.22 M for the last quarter. The previous quarter showed -40.83 M, which means net income changed by -22.97%.
Is Dianthus Therapeutics, Inc. Common Stock a good dividend stock?
Dianthus Therapeutics, Inc. Common Stock currently has a dividend yield of 0%. Previously, the dividend yield was 0%, compared with 0% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Dianthus Therapeutics, Inc. Common Stock have?
As of the latest available data, Dianthus Therapeutics, Inc. Common Stock has 92 employees. Workforce size can provide additional context about the company's scale and operations.
What is Dianthus Therapeutics, Inc. Common Stock EBITDA?
Dianthus Therapeutics, Inc. Common Stock EBITDA is -56.33 M, and its EBITDA margin is -488.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Dianthus Therapeutics, Inc. Common Stock stock?
You can buy Dianthus Therapeutics, Inc. Common Stock (DNTH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Dianthus Therapeutics, Inc. Common Stock stock?
Investing in Dianthus Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DNTH chart and related analysis on metatrader.com as part of your research.